247 related articles for article (PubMed ID: 31902694)
1. Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion.
Blackburn PR; Huang L; Dalovisio A; Pitel BA; Chen D; Oliveira JL; Wood AJ; Smadbeck JB; Johnson SH; Vasmatzis G; Haferlach C; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Peterson JF
Cancer Genet; 2020 Feb; 241():67-71. PubMed ID: 31902694
[TBL] [Abstract][Full Text] [Related]
2. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
[TBL] [Abstract][Full Text] [Related]
3. A rare presentation of BCR-ABL1 and RUNX1-MECOM rearrangement in a pediatric patient with acute myeloid leukemia.
Alamri RM; Alanazi M; AlRajeh RK; Tashkandi SA; Alswayyed AF; Samman MA; Peer-Zada AA
Clin Case Rep; 2024 May; 12(5):e8917. PubMed ID: 38751957
[TBL] [Abstract][Full Text] [Related]
4. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
[TBL] [Abstract][Full Text] [Related]
5. Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
Ottema S; Mulet-Lazaro R; Beverloo HB; Erpelinck C; van Herk S; van der Helm R; Havermans M; Grob T; Valk PJM; Bindels E; Haferlach T; Haferlach C; Smeenk L; Delwel R
Blood; 2020 Jul; 136(2):224-234. PubMed ID: 32219447
[TBL] [Abstract][Full Text] [Related]
6. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A
BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459
[TBL] [Abstract][Full Text] [Related]
7. De Novo Acute Myeloid Leukemia with Combined
Sethapati VR; Jabr R; Shune L; El Atrouni W; Gonzales PR; Cui W; Golem S
Case Rep Hematol; 2020; 2020():8822670. PubMed ID: 33489389
[TBL] [Abstract][Full Text] [Related]
8. p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16).
Dai HP; Xue YQ; Wu LL; Pan JL; Gong YL; Wu YF; Zhang J; Wu DP; Chen SN
Int J Hematol; 2012 Dec; 96(6):814-7. PubMed ID: 23054652
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms.
George TI; Bajel A
Pathology; 2021 Apr; 53(3):312-327. PubMed ID: 33676766
[TBL] [Abstract][Full Text] [Related]
11. BCR-ABL1(+) acute myeloid leukemia: clonal selection of a BCR-ABL1(-) subclone as a cause of refractory disease with nilotinib treatment.
Neuendorff NR; Schwarz M; Hemmati P; Türkmen S; Bommer C; Burmeister T; Dörken B; le Coutre P; Arnold R; Westermann J
Acta Haematol; 2015; 133(2):237-41. PubMed ID: 25401297
[TBL] [Abstract][Full Text] [Related]
12. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and laboratory characteristics of 12 Ph/BCR-ABL positive acute myeloid leukemia patients].
Cai W; He X; Chen S; Sun A; He J; Zhu M; Wu D
Zhonghua Xue Ye Xue Za Zhi; 2015 May; 36(5):398-402. PubMed ID: 26031527
[TBL] [Abstract][Full Text] [Related]
14. Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.
Sindt A; Deau B; Brahim W; Staal A; Visanica S; Villarese P; Rault JP; Macintyre E; Delabesse E
Genes Chromosomes Cancer; 2006 Jun; 45(6):575-82. PubMed ID: 16518848
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
Orsmark-Pietras C; Landberg N; Lorenz F; Uggla B; Höglund M; Lehmann S; Derolf Å; Deneberg S; Antunovic P; Cammenga J; Möllgård L; Wennström L; Lilljebjörn H; Rissler M; Fioretos T; Lazarevic VL
Genes Chromosomes Cancer; 2021 Jun; 60(6):426-433. PubMed ID: 33433047
[TBL] [Abstract][Full Text] [Related]
16. Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case report.
Lewen M; Gresh R; Queenan M; Paessler M; Pillai V; Hexner E; Frank D; Bagg A; Aplenc R; Caywood E; Wertheim G
Biomark Res; 2016; 4():14. PubMed ID: 27453784
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors.
Theil KS; Cotta CV
Cancer Genet; 2014 May; 207(5):171-6. PubMed ID: 25027637
[TBL] [Abstract][Full Text] [Related]
18. Use of mate-pair sequencing to characterize a complex cryptic BCR/ABL1 rearrangement observed in a newly diagnosed case of chronic myeloid leukemia.
Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Kearney HM; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP
Hum Pathol; 2019 Jul; 89():109-114. PubMed ID: 30267776
[TBL] [Abstract][Full Text] [Related]
19. Acute Megakaryoblastic Leukemia Harboring a Subclone Expressing BCR-ABL1 Fusion Gene Product.
Kashima E; Nakano E; Watanabe Y; Imai H; Oka K; Kageyama S; Tanaka I
Intern Med; 2021 Nov; 60(22):3609-3614. PubMed ID: 34053988
[TBL] [Abstract][Full Text] [Related]
20. EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis.
Yamaoka A; Suzuki M; Katayama S; Orihara D; Engel JD; Yamamoto M
Blood Adv; 2020 Apr; 4(8):1722-1736. PubMed ID: 32330245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]